Friday, October 31, 2014 8:52:59 AM
No, Ebola is just the last global health crisis used by Hemispherx Biopharma(HEB) CEO Bill Carter to pad his pockets with shareholder cash. Every few years, a nasty virus grabs headlines, and like clockwork, Hemispherx issues a flurry of hyper-promotional press releases claiming that one or both of its never-done-anything drugs is a potential cure. The press releases are designed to pump Hemispherx's stock price higher so the company can raise money. That money is used to pay Carter's outrageously high salary and bonuses. Very little, if any, of the money is funneled into real clinical trials.
Here's the most recent example: On Thursday, Hemispherx issued a press release claiming the publication of a "peer-reviewed" study in a medical journal describing how the chemical structure of the Ebola virus is well suited for treatment with the company's experimental drug Ampligen. "Peer reviewed" implies an objective review and endorsement of the study.
Turns out the publication was not a study, only a letter co-written by Carter and Dr. William Mitchell, a Hemispherx director and the company's scientific bag man. Carter and Mitchell submitted their letter to the medical journal on Sept. 18 and it was accepted for publication on Sept. 22. Not much time for "peer review."
So many people think AF is scum because he doesn't write to their agenda. He is nothing but honest in this statement. The company is a Trial company. Run as many trials as possible to make themselves look like a biotech. Sad but true, he is just stealing the publics money and someone should stop him.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM